Daichao Wu

6PUBLICATIONS
27CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 10, 2025
Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes.

Ping Yuan, Guodong Chen, Yukun Li

|Nov 22, 2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens.

Daichao Wu, Rui Yin, Guodong Chen

|Sep 28, 2024
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.

Zhouchi Yao, Yayun Zeng, Cheng Liu

|Oct 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.

Cecily Choy, Joseph Chen, Jiangyuan Li

|Jan 11, 2022
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.

Daichao Wu, Alexander Kolesnikov, Rui Yin

|Feb 11, 2021
FGFR-TKI resistance in cancer: current status and perspectives.

Sitong Yue, Yukun Li, Xiaojuan Chen

Pageof 1

Frequent Collaborators

4 joint publications

Brian G Pierce

4 joint publications

Roy Mariuzza

3 joint publications

Rui Yin

1 joint publications

Johnathan D Guest